ResMed Inc (RMD)
NYSE • Healthcare
April 2, 2026 at 20:00 UTC
About ResMed Inc
ResMed Inc is a medical technology company focused on sleep and respiratory care, pairing devices and software with programs that help patients stay on therapy. The business works where home care meets clinical oversight: equipment is designed for comfort and consistency, data flows to caregivers through secure channels, and support helps people manage therapy without turning it into a project. Providers use connected workflows to onboard patients, monitor adherence, and coordinate service visits in measured steps rather than emergency bursts. The operating principle is calm reliability — make equipment easy to live with, keep information clear for clinicians, and resolve issues quickly. Within healthcare, ResMed occupies the connective layer between prescription and daily use, helping long-term therapies fit ordinary routines.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
ResMed Inc's Technical Indicators Summary
RMD exhibits a bearish technical stance characterized by a strong ADX that underscores the prevailing downtrend and negative volume on OBV indicating distribution. Price sits below most short- to long-term moving averages, including the 200-day, while momentum measures register weakness and MACD is not providing bullish confirmation. Volatility by ATR is moderate, and classic pivots offer a nearby reference near the current level. Technical takeaway: trend strength and volume favor the downside, with moving averages and momentum aligning toward bearish conditions.
| Indicator | Value |
|---|---|
RSI (14) | 34.89 |
Stochastic %K (14, 3, 3) | 29.81 |
CCI (20) | -73.30 |
WPR (14) | -66.03 |
Momentum (10) | -3.32 |
MFI | 26.48 |
MACD Level (12, 26) | -7.56 |
Bollinger Bands | $211.15 - $250.71 |
ATR (14) | $6.21 (2.77%) |
ADX (14) | 36.78 |
OBV | -5,957,200 |
Classic Pivot Point | $223.22 |
Fibonacci Pivot Point | $223.22 |
Exponential Moving Averages | $225.30 - $251.86(5 indicators) |
Simple Moving Averages | $224.29 - $258.95(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
By the close, RMD remained slightly above yesterday’s 222.85, with a small 0.56% gap leaving it around 224.09. The day closed with light sector weakness (-0.62%), providing a gentle headwind. RMD edges higher after ResMed beat earnings estimates and announced a dividend, offsetting sector weakness.
Price Change
from $224.1 close
+$0.09
Trading Volume
Below avg (1.1M)
444.3K
vs S&P 500 Today
Outperforming Market
+1.13%
52-Week Position
Lower range
25.7%
Updated: April 3, 2026 at 20:10 UTC
Quote Summary
RMD Headlines
2025 Valuation Insights: Spotify, Aker BP, and Key Growth Stocks
December 7, 2025